epirubicin has been researched along with Leukemia, Myeloid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baubion, N; Buzyn, A; Decaudin, D; Delarue, R; Fourquet, A; Ghez, D; Hermine, O; Messas, E; Rubio, MT; Suarez, F; Varet, B; Willems, L | 1 |
| Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR | 1 |
| Daniel, PT; Dörken, B; Essmann, F; Geilen, CC; Müller, A; Schmelz, K; Schulze-Osthoff, K; Tamm, I; Wieder, T | 1 |
| Alimonti, A; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Ferretti, G; Nardoni, C; Papaldo, P; Ruggeri, EM | 1 |
| Bonneterre, J; Campone, M; Fargeot, P; Fumoleau, P; Goudier, MJ; Kerbrat, P; Monnier, A; Montcuquet, P; Namer, M; Roché, H; Romestaing, P | 1 |
| Adamczyk-Cioch, MB; Dmoszyńska, A; Hus, I; Hus, M | 1 |
| Davey, MW; Davey, RA; Marks, DC; Su, GM | 1 |
| Anker, G; Bengtsson, NO; Bergh, J; Blomqvist, C; Erikstein, B; Holte, H; Kellokumpu-Lehtinen, P; Lidbrink, E; Lindman, H; Ljungman, P; Malmström, P; Nilsson, J; Ottosson, S; Salminen, E; Söderlund, G; Wiklund, T; Wilking, N; Wist, E | 1 |
| Ames, MM; Kuffel, MJ; Reid, JM | 1 |
| Bonacina, E; Cattaneo, M; di Massino, UV; Fesslova, V; Figini, A; Galli, MA; Jankovic, M; Masera, G; Ottaviani, V; Uderzo, C | 1 |
3 review(s) available for epirubicin and Leukemia, Myeloid
| Article | Year |
|---|---|
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2003 |
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Incidence; Leukemia, Myeloid; Middle Aged; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Risk Factors; Stereoisomerism; Survival Rate | 2005 |
Cardiac relapses in myeloid leukemia: case report and review of the literature.
Topics: Cardiomyopathies; Child; Doxorubicin; Epirubicin; Female; Heart Failure; Heart Neoplasms; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mastoiditis; Myocardium; Skull Neoplasms | 1987 |
2 trial(s) available for epirubicin and Leukemia, Myeloid
| Article | Year |
|---|---|
Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Risk Factors | 2005 |
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
Topics: Acute Disease; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Proportional Hazards Models; Sweden; Thiotepa | 2000 |
5 other study(ies) available for epirubicin and Leukemia, Myeloid
| Article | Year |
|---|---|
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Daunorubicin; Epirubicin; Female; Fluorouracil; Heart Diseases; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Middle Aged; Neoplasms, Second Primary; Remission Induction; Stroke Volume | 2010 |
Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Topics: Adult; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Northern; Caspase 8; Caspases; Cell Death; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hodgkin Disease; Humans; Intracellular Membranes; Leukemia, Myeloid; Membrane Potentials; Mitochondria; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sphingomyelins; Tumor Necrosis Factor-alpha | 2004 |
[Clinical and immunologic characteristics of CD 34 positive acute myeloid leukemia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Remission Induction | 1995 |
Extended multidrug resistance in haemopoietic cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hematopoietic Stem Cells; HL-60 Cells; Humans; Leukemia, Myeloid; Paclitaxel; Tumor Cells, Cultured; Vinblastine | 1996 |
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1992 |